Objective: The non-epithelial neoplasms of larynx and hypopharynx are of rare incidence but may originate from various histological tissues. These effect in the difficulty of final diagnosis and often delay the proper treatment.
Material And Methods: There was performed retrospective analysis of patients with histopathologicaly confirmed non-epithelial neoplasms of larynx or hypopharynx between 2001 and 2013, that included the evaluation of epidemiology, diagnostic methods and treatment.
Results: Non-epithelial neoplasms of larynx and hypopharynx were established in 18 patients (9 women, 9 men), mean age - 60,3 years. The malignant neoplasms were diagnosed in 10 patients and benign - in 8. The soft tissue neoplasms were the most common - 8 patients. There were also 4 lymphomas, 4 chondrosarcomas, 1 paraganglioma and 1 malignant melanoma. Tumors manifested clinically as covered by unchanged mucosa. Characteristic features were observed on computed tomography for certain cases of these neoplasms. The results of the tumor biopsy were in most of the cases not diagnostic. Intralaryngeal microsurgery was applied in benign neoplasms, chemiotherapy - for lymphomas and total laryngectomy for chondrosarcomas and malignant melanoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5604/00306657.1170420 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Isothiocyanates induce autophagy and inhibit protein synthesis in primary cells via modulation of AMPK-mTORC1-S6K1 signaling pathway, and protect against mutant huntingtin aggregation.
Eur J Nutr
December 2024
Department of Medical Biology and Genetics, Faculty of Biology, University of Gdansk, Wita Stwosza 59, Gdansk, 80-308, Poland.
Purpose: Autophagy is a degradation process whose activation underlies beneficial effects of caloric restriction. Isothiocyanates (ITCs) induce autophagy in cancer cells, however, their impact on primary cells remains insufficiently explored, particularly in non-epithelial cells. The aim of this study was to investigate whether ITCs induce autophagy in primary (non-immortalized) mesenchymal cells and if so, to determine the molecular mechanism underlying its activation and consequences on cell functioning.
View Article and Find Full Text PDFNationwide questionnaire survey on pediatric pancreatic tumors in Japan.
World J Gastrointest Oncol
October 2024
Department of Pediatric Surgery, Shizuoka Children's Hospital, Shizuoka 420-8660, Japan.
Background: Pediatric pancreatic tumors are rare and account for < 0.1% of all childhood cancers. The primary treatment for pancreatic tumors is surgical resection.
View Article and Find Full Text PDFOn Vascular Lesions of the Thyroid Gland with Emphasis on Intrathyroidal Hemangioma: Clinicopathologic Characterization of Two Cases and Review of the Literature.
Head Neck Pathol
October 2024
Division of Oral and Maxillofacial Pathology, The Ohio State University College of Dentistry, Postle Hall, Room 2191 305 W. 12th Ave, Columbus, OH, 43210, USA.
Article Synopsis
- Two cases of thyroid hemangioma were observed in a 62-year-old man and an 18-year-old woman, showing characteristics like mobile nodules and specific vascular indicators under microscopic examination.
- A review of existing literature found 53 cases of intrathyroidal hemangiomas, mostly in the right thyroid lobe, primarily showing features of cavernous hemangiomas, with favorable prognosis and surgical resection deemed curative due to diagnostic challenges.
Preclinical/clinical trials of thrice-weekly administration of a combination of tegafur/gimeracil/oteracil (TS-1) and toceranib phosphate in dogs with intranasal tumors.
J Vet Med Sci
November 2024
Veterinary Teaching Hospital, Azabu University, Kanagawa, Japan.
Article Synopsis
- Intranasal tumors in dogs are mainly malignant and treated with radiotherapy, but they often return after treatment; combining therapies can improve outcomes.
- The study tested a combination of two drugs, TS-1 and toceranib phosphate, to determine a safe dosage for dogs with these tumors, using a cohort design to assess safety over a month.
- Results showed that the maximum TS-1 dose of 2.0 mg/kg combined with 2.4 mg/kg of toceranib phosphate thrice weekly was well-tolerated, indicating that this combination therapy is safe for treating canine intranasal tumors.
SATB2 expression in oral sarcomatoid (spindle cell) squamous cell carcinoma: clinicopathologic and immunophenotypic characterization of 10 cases.
Oral Surg Oral Med Oral Pathol Oral Radiol
January 2025
Division of Oral and Maxillofacial Pathology, The Ohio State University College of Dentistry, Columbus, OH, USA.
Article Synopsis
- The study investigates 10 cases of sarcomatoid squamous cell carcinoma (sSCC), a rare type of oral cancer, examining their clinicopathologic and immunophenotypic characteristics, particularly looking at SATB2 expression.
- These cases, collected from 2000 to 2023, primarily affected older adults with a male-to-female ratio of 1.5:1, most commonly occurring in the tongue, and showed a variety of tumor appearances and microscopic features.
- Results indicated that while all lesions tested positive for certain markers, SATB2 expression can vary significantly and may lead to misdiagnosis, highlighting the importance of using multiple markers for accurate identification of oral s
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!